HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Middle East and North Africa  /  EGY

Egypt

Egypt appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

61,000
People living with HIV, 2025
WHO Global Health Observatory
48.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$36k
United States HIV disbursements, 2016
OECD Creditor Reporting System
$1.7m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$2.5m$5m$7.5m20012004200720102013201620192022$1.7m$36k$1.6m$93k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2001 — — — $3k
2002 $702k — — —
2003 $1.2m $184k — $10k
2004 $1.9m $859k — $675k
2005 $604k $41k — $225k
2006 $1.1m $224k — $24k
2007 $1.4m — — $200k
2008 $3.6m $87k $2.3m $32k
2009 $4.2m $290k $2.7m $295k
2010 $3.8m $372k $1.4m $320k
2011 $1.4m $525k — $566k
2012 $2.6m $42k $1.8m $102k
2013 $1.7m — $771k $922k
2014 $435k $11k — $62k
2015 $735k $190k $211k $43k
2016 $388k $36k $9k $93k
2017 $742k — $274k —
2018 $328k — — —
2019 $194k — — —
2020 $1.7m — $1.7m —
2021 $3.4m — $3.3m —
2022 $7.7m — $7.7m —
2023 $8.5m — $8.2m —
2024 $1.7m — $1.6m —

24 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
025k50k75k20002003200620092012201520182021202456,00025,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 14,000 9,600 19,000 —
2001 14,000 10,000 19,000 —
2002 15,000 11,000 19,000 —
2003 15,000 11,000 20,000 —
2004 16,000 12,000 20,000 —
2005 17,000 13,000 21,000 —
2006 17,000 13,000 22,000 —
2007 18,000 14,000 23,000 —
2008 19,000 15,000 24,000 —
2009 20,000 15,000 25,000 —
2010 21,000 16,000 27,000 580
2011 22,000 17,000 28,000 740
2012 23,000 18,000 30,000 940
2013 24,000 19,000 32,000 1,200
2014 26,000 20,000 34,000 1,800
2015 27,000 21,000 37,000 2,200
2016 29,000 22,000 39,000 3,200
2017 31,000 24,000 42,000 4,800
2018 34,000 26,000 45,000 6,700
2019 37,000 28,000 49,000 8,400
2020 40,000 30,000 54,000 10,000
2021 43,000 32,000 58,000 12,000
2022 47,000 35,000 63,000 16,000
2023 51,000 38,000 70,000 19,000
2024 56,000 41,000 77,000 25,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
-20%0%20%40%60%2010201220142016201820202022202459.0%45.0%36.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 8.0% 3.0% —
2011 9.0% 3.0% —
2012 11.0% 4.0% —
2013 13.0% 5.0% —
2014 17.0% 7.0% —
2015 20.0% 8.0% —
2016 24.0% 11.0% —
2017 29.0% 15.0% —
2018 33.0% 20.0% —
2019 37.0% 23.0% —
2020 41.0% 26.0% —
2021 45.0% 29.0% —
2022 50.0% 34.0% 28.0%
2023 54.0% 38.0% 33.0%
2024 59.0% 45.0% 36.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Egypt

2,756 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 781 27 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 247 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 116 17 2000–2025 extranet.who.int 2026-10-16
IATI, through d-portal Expenditure account 57 3 2000–2026 d-portal.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
OECD Creditor Reporting System Expenditure account 48 3 2002–2024 sdmx.oecd.org 2026-10-12
ForeignAssistance.gov Expenditure account 30 2 2001–2016 foreignassistance.gov 2026-10-29
WHO HIV testing services dashboard Programme record 19 2 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
Global Fund Data Service Programme record 16 4 2019–2025 fetch.theglobalfund.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 9 9 2023 hivfinancial.unaids.org 2026-10-12
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 2 2 2023 aidsinfo.unaids.org 2026-10-15

Indicators held

59 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 2 2022–2024 WHO Global Tuberculosis Programme $10k (2024)
Budget required for collaborative TB/HIV activities Financing USD 3 2023–2025 WHO Global Tuberculosis Programme $185k (2025)
Country-reported HIV expenditure, all sources Financing USD 2 2023 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $25.5m (2023)
Domestic funding received by the national TB programme Financing USD 3 2017–2024 WHO Global Tuberculosis Programme $2.3m (2024)
Domestic public HIV expenditure Financing USD 2 2023 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $25.1m (2023)
Expected Global Fund funding for the national TB programme Financing USD 4 2022–2025 WHO Global Tuberculosis Programme $830k (2025)
Expected USAID funding for the national TB programme Financing USD 2 2022–2024 WHO Global Tuberculosis Programme $0 (2024)
Expected domestic funding for the national TB programme Financing USD 4 2022–2025 WHO Global Tuberculosis Programme $100k (2025)
Expected funding for collaborative TB/HIV activities Financing USD 3 2023–2025 WHO Global Tuberculosis Programme $10k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $1.7m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 26 2000–2025 IATI, through d-portal $0 (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $39k (2026)
External HIV financing from the United States (ODA) Financing USD 27 2001–2016 ForeignAssistance.gov, OECD Creditor Reporting System $36k (2016)
Funding received for collaborative TB/HIV activities Financing USD 3 2017–2024 WHO Global Tuberculosis Programme $10k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 5,573,189 (2026)
Global Fund HIV disbursements to the country Financing USD 30 2008–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $2.9m (2026)
Global Fund funding received by the national TB programme Financing USD 3 2017–2024 WHO Global Tuberculosis Programme $200k (2024)
HIV spending on TB/HIV co-infection Financing USD 1 2023 UNAIDS Global AIDS Monitoring expenditure database $145k (2023)
HIV spending on prevention Financing USD 1 2023 UNAIDS Global AIDS Monitoring expenditure database $49k (2023)
HIV spending on prevention of vertical transmission Financing USD 1 2023 UNAIDS Global AIDS Monitoring expenditure database $1k (2023)
HIV spending on treatment, care and support Financing USD 1 2023 UNAIDS Global AIDS Monitoring expenditure database $25.3m (2023)
International HIV expenditure (country-reported) Financing USD 2 2023 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $410k (2023)
Other bilateral HIV expenditure (country-reported) Financing USD 1 2023 UNAIDS Global AIDS Monitoring expenditure database $197k (2023)
US HIV disbursements managed by USAID Financing USD 15 2001–2016 ForeignAssistance.gov $93k (2016)
USAID funding received by the national TB programme Financing USD 1 2017 WHO Global Tuberculosis Programme $0 (2017)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 7 2022–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 38.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 48.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 29 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 64.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 20 2003–2024 UNAIDS AIDSinfo 68.5% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2023–2024 UNAIDS AIDSinfo 1.2% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 6 2013–2024 UNAIDS AIDSinfo 2.8% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2022–2024 UNAIDS AIDSinfo 6.1% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 4 2022–2025 WHO Global Health Observatory 80.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 20 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.2% (2024)
HIV tests performed with the result returned to the person Treatment cascade count 21 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 3,217,581 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 15 2010–2024 UNAIDS AIDSinfo 16.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 14 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 219 (2025)
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 1 2020 UNAIDS AIDSinfo 30.0% (2020)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 76 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 29,336 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 38.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 4 2022–2025 Global Fund Data Service 1,202 (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 1 2025 Global Fund Data Service 4,125 (2025)
People newly enrolled on ART during the year Treatment cascade count 6 2013–2024 WHO Global Tuberculosis Programme 5,043 (2024)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 5 2020–2024 UNAIDS AIDSinfo 98.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 260 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 143 (2024)
TB patients with an HIV test result recorded Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 8,035 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 1,300 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 32 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.1% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 210 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 6,300 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 61,000 (2025)
Male condoms distributed in a year Prevention and outreach count 4 2020–2024 UNAIDS AIDSinfo 336,522 (2024)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 680 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 118,365,995 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 29.8% (2025)

Every row shown on the Egypt page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.